<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35272713</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>29</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2049-2618</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Mar</Month><Day>11</Day></PubDate></JournalIssue><Title>Microbiome</Title><ISOAbbreviation>Microbiome</ISOAbbreviation></Journal><ArticleTitle>The microbiota restrains neurodegenerative microglia in a model of amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>47</StartPage><MedlinePgn>47</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">47</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40168-022-01232-z</ELocationID><Abstract><AbstractText Label="BACKGROUND">The gut microbiota can affect neurologic disease by shaping microglia, the primary immune cell in the central nervous system (CNS). While antibiotics improve models of Alzheimer's disease, Parkinson's disease, multiple sclerosis, and the C9orf72 model of amyotrophic lateral sclerosis (ALS), antibiotics worsen disease progression the in SOD1<sup>G93A</sup> model of ALS. In ALS, microglia transition from a homeostatic to a neurodegenerative (MGnD) phenotype and contribute to disease pathogenesis, but whether this switch can be affected by the microbiota has not been investigated.</AbstractText><AbstractText Label="RESULTS">In this short report, we found that a low-dose antibiotic treatment worsened motor function and decreased survival in the SOD1 mice, which is consistent with studies using high-dose antibiotics. We also found that co-housing SOD1 mice with wildtype mice had no effect on disease progression. We investigated changes in the microbiome and found that antibiotics reduced Akkermansia and butyrate-producing bacteria, which may be beneficial in ALS, and cohousing had little effect on the microbiome. To investigate changes in CNS resident immune cells, we sorted spinal cord microglia and found that antibiotics downregulated homeostatic genes and increased neurodegenerative disease genes in SOD1 mice. Furthermore, antibiotic-induced changes in microglia preceded changes in motor function, suggesting that this may be contributing to disease progression.</AbstractText><AbstractText Label="CONCLUSIONS">Our findings suggest that the microbiota play a protective role in the SOD1 model of ALS by restraining MGnD microglia, which is opposite to other neurologic disease models, and sheds new light on the importance of disease-specific interactions between microbiota and microglia. Video abstract.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Cox</LastName><ForeName>Laura M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham &amp; Women's Hospital, Boston, MA, 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Calcagno</LastName><ForeName>Narghes</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham &amp; Women's Hospital, Boston, MA, 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gauthier</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham &amp; Women's Hospital, Boston, MA, 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madore</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham &amp; Women's Hospital, Boston, MA, 02115, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bordeaux University, INRAE, Bordeaux INP, NutriNeuro, UMR 1286, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butovsky</LastName><ForeName>Oleg</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham &amp; Women's Hospital, Boston, MA, 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weiner</LastName><ForeName>Howard L</ForeName><Initials>HL</Initials><AffiliationInfo><Affiliation>Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham &amp; Women's Hospital, Boston, MA, 02115, USA. hweiner@rics.bwh.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01NS088137</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01AG054672</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01NS115951</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01AG051812</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS115951</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Microbiome</MedlineTA><NlmUniqueID>101615147</NlmUniqueID><ISSNLinking>2049-2618</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064307" MajorTopicYN="Y">Microbiota</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>11</Day><Hour>5</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35272713</ArticleId><ArticleId IdType="pmc">PMC8915543</ArticleId><ArticleId IdType="doi">10.1186/s40168-022-01232-z</ArticleId><ArticleId IdType="pii">10.1186/s40168-022-01232-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al-Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 2013;9:617&#x2013;628. doi: 10.1038/nrneurol.2013.203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.203</ArticleId><ArticleId IdType="pubmed">24126629</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson J, Amor S. Modelling amyotrophic lateral sclerosis in mice. Drug Discov Today Dis Models. 2017;25-26:35&#x2013;44. doi: 10.1016/j.ddmod.2018.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ddmod.2018.10.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med. 2016;375:2369&#x2013;2379. doi: 10.1056/NEJMra1600266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1600266</ArticleId><ArticleId IdType="pubmed">27974040</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox LM, Weiner HL. Microbiota signaling pathways that influence neurologic disease. Neurotherapeutics. 2018;15:135&#x2013;145. doi: 10.1007/s13311-017-0598-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-017-0598-8</ArticleId><ArticleId IdType="pmc">PMC5794708</ArticleId><ArticleId IdType="pubmed">29340928</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D, et al. The fecal microbiome of ALS patients. Neurobiol Aging. 2018;61:132&#x2013;137. doi: 10.1016/j.neurobiolaging.2017.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.09.023</ArticleId><ArticleId IdType="pubmed">29065369</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacher E, et al. Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature. 2019;572:474&#x2013;480. doi: 10.1038/s41586-019-1443-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1443-5</ArticleId><ArticleId IdType="pubmed">31330533</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholson K, et al. The human gut microbiota in people with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2021;22:186&#x2013;194. doi: 10.1080/21678421.2020.1828475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1828475</ArticleId><ArticleId IdType="pubmed">33135936</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowin J, Xia Y, Jung B, Sun J. Gut inflammation and dysbiosis in human motor neuron disease. Physiol Rep. 2017;5. 10.14814/phy2.13443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5617930</ArticleId><ArticleId IdType="pubmed">28947596</ArticleId></ArticleIdList></Reference><Reference><Citation>Berer K, et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature. 2011;479:538&#x2013;541. doi: 10.1038/nature10554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10554</ArticleId><ArticleId IdType="pubmed">22031325</ArticleId></ArticleIdList></Reference><Reference><Citation>Minter MR, et al. Antibiotic-induced perturbations in microbial diversity during post-natal development alters amyloid pathology in an aged APPSWE/PS1DeltaE9 murine model of Alzheimer's disease. Sci Rep. 2017;7:10411. doi: 10.1038/s41598-017-11047-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-11047-w</ArticleId><ArticleId IdType="pmc">PMC5585265</ArticleId><ArticleId IdType="pubmed">28874832</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampson TR, et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson&#x2019;s disease. Cell. 2016;167:1469&#x2013;1480.e1412. doi: 10.1016/j.cell.2016.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.11.018</ArticleId><ArticleId IdType="pmc">PMC5718049</ArticleId><ArticleId IdType="pubmed">27912057</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YK, Menezes JS, Umesaki Y, Mazmanian SK. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A. 2011;108(Suppl 1):4615&#x2013;4622. doi: 10.1073/pnas.1000082107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1000082107</ArticleId><ArticleId IdType="pmc">PMC3063590</ArticleId><ArticleId IdType="pubmed">20660719</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller PG, Bonn MB, Franklin CL, Ericsson AC, McKarns SC. TNFR2 deficiency acts in concert with gut microbiota to precipitate spontaneous sex-biased central nervous system demyelinating autoimmune disease. J Immunol. 2015;195:4668&#x2013;4684. doi: 10.4049/jimmunol.1501664.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1501664</ArticleId><ArticleId IdType="pmc">PMC8449043</ArticleId><ArticleId IdType="pubmed">26475926</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochoa-Reparaz J, Mielcarz DW, Haque-Begum S, Kasper LH. Induction of a regulatory B cell population in experimental allergic encephalomyelitis by alteration of the gut commensal microflora. Gut Microbes. 2010;1:103&#x2013;108. doi: 10.4161/gmic.1.2.11515.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/gmic.1.2.11515</ArticleId><ArticleId IdType="pmc">PMC3023588</ArticleId><ArticleId IdType="pubmed">21326918</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, et al. Antibiotics use and risk of amyotrophic lateral sclerosis in Sweden. Eur J Neurol. 2019;26:1355&#x2013;1361. doi: 10.1111/ene.13986.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13986</ArticleId><ArticleId IdType="pubmed">31087715</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasemann S, et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity. 2017;47:566&#x2013;581.e569. doi: 10.1016/j.immuni.2017.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2017.08.008</ArticleId><ArticleId IdType="pmc">PMC5719893</ArticleId><ArticleId IdType="pubmed">28930663</ArticleId></ArticleIdList></Reference><Reference><Citation>Appel SH, Zhao W, Beers DR, Henkel JS. The microglial-motoneuron dialogue in ALS. Acta Myol. 2011;30:4&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3185827</ArticleId><ArticleId IdType="pubmed">21842586</ArticleId></ArticleIdList></Reference><Reference><Citation>Boillee S, et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 2006;312:1389&#x2013;1392. doi: 10.1126/science.1123511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1123511</ArticleId><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, et al. Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in amyotrophic lateral sclerosis. PLoS One. 2012;7:e39216. doi: 10.1371/journal.pone.0039216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0039216</ArticleId><ArticleId IdType="pmc">PMC3375234</ArticleId><ArticleId IdType="pubmed">22720079</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O, et al. Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice. Ann Neurol. 2015;77:75&#x2013;99. doi: 10.1002/ana.24304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24304</ArticleId><ArticleId IdType="pmc">PMC4432483</ArticleId><ArticleId IdType="pubmed">25381879</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O, et al. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J Clin Invest. 2012;122:3063&#x2013;3087. doi: 10.1172/JCI62636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI62636</ArticleId><ArticleId IdType="pmc">PMC3428086</ArticleId><ArticleId IdType="pubmed">22863620</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis. 2004;15:601&#x2013;609. doi: 10.1016/j.nbd.2003.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2003.12.012</ArticleId><ArticleId IdType="pubmed">15056468</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel JS, et al. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol. 2004;55:221&#x2013;235. doi: 10.1002/ana.10805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.10805</ArticleId><ArticleId IdType="pubmed">14755726</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhle J, et al. Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis. Eur J Neurol. 2009;16:771&#x2013;774. doi: 10.1111/j.1468-1331.2009.02560.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2009.02560.x</ArticleId><ArticleId IdType="pubmed">19236470</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryberg H, et al. Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics. Muscle Nerve. 2010;42:104&#x2013;111. doi: 10.1002/mus.21683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.21683</ArticleId><ArticleId IdType="pmc">PMC2975276</ArticleId><ArticleId IdType="pubmed">20583124</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K, et al. Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice. Proc Natl Acad Sci U S A. 2008;105:7594&#x2013;7599. doi: 10.1073/pnas.0802556105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0802556105</ArticleId><ArticleId IdType="pmc">PMC2396671</ArticleId><ArticleId IdType="pubmed">18492803</ArticleId></ArticleIdList></Reference><Reference><Citation>Erny D, et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci. 2015;18:965&#x2013;977. doi: 10.1038/nn.4030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4030</ArticleId><ArticleId IdType="pmc">PMC5528863</ArticleId><ArticleId IdType="pubmed">26030851</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodiya HB, et al. Sex-specific effects of microbiome perturbations on cerebral Abeta amyloidosis and microglia phenotypes. J Exp Med. 2019;216:1542&#x2013;1560. doi: 10.1084/jem.20182386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20182386</ArticleId><ArticleId IdType="pmc">PMC6605759</ArticleId><ArticleId IdType="pubmed">31097468</ArticleId></ArticleIdList></Reference><Reference><Citation>Burberry A, et al. C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. Nature. 2020;582:89&#x2013;94. doi: 10.1038/s41586-020-2288-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2288-7</ArticleId><ArticleId IdType="pmc">PMC7416879</ArticleId><ArticleId IdType="pubmed">32483373</ArticleId></ArticleIdList></Reference><Reference><Citation>Minter MR, et al. Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer&#x2019;s disease. Sci Rep. 2016;6:30028. doi: 10.1038/srep30028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep30028</ArticleId><ArticleId IdType="pmc">PMC4956742</ArticleId><ArticleId IdType="pubmed">27443609</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, et al. Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer&#x2019;s disease progression. Cell Res. 2019;29:787&#x2013;803. doi: 10.1038/s41422-019-0216-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-019-0216-x</ArticleId><ArticleId IdType="pmc">PMC6796854</ArticleId><ArticleId IdType="pubmed">31488882</ArticleId></ArticleIdList></Reference><Reference><Citation>Benakis C, et al. Commensal microbiota affects ischemic stroke outcome by regulating intestinal gammadelta T cells. Nat Med. 2016;22:516&#x2013;523. doi: 10.1038/nm.4068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4068</ArticleId><ArticleId IdType="pmc">PMC4860105</ArticleId><ArticleId IdType="pubmed">27019327</ArticleId></ArticleIdList></Reference><Reference><Citation>Regen T, et al. IL-17 controls central nervous system autoimmunity through the intestinal microbiome. Sci Immunol. 2021;6. 10.1126/sciimmunol.aaz6563.</Citation><ArticleIdList><ArticleId IdType="pubmed">33547052</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, et al. Gut microbiota from NLRP3-deficient mice ameliorates depressive-like behaviors by regulating astrocyte dysfunction via circHIPK2. Microbiome. 2019;7:116. doi: 10.1186/s40168-019-0733-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-019-0733-3</ArticleId><ArticleId IdType="pmc">PMC6706943</ArticleId><ArticleId IdType="pubmed">31439031</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott S, et al. Design, power, and interpretation of studies in the standard murine model of ALS. Amyotroph Lateral Scler. 2008;9:4&#x2013;15. doi: 10.1080/17482960701856300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960701856300</ArticleId><ArticleId IdType="pubmed">18273714</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatzipetros T, et al. A quick phenotypic neurological scoring system for evaluating disease progression in the SOD1-G93A mouse model of ALS. J Vis Exp. 2015. 10.3791/53257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4692639</ArticleId><ArticleId IdType="pubmed">26485052</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O, et al. Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat Neurosci. 2014;17:131&#x2013;143. doi: 10.1038/nn.3599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3599</ArticleId><ArticleId IdType="pmc">PMC4066672</ArticleId><ArticleId IdType="pubmed">24316888</ArticleId></ArticleIdList></Reference><Reference><Citation>Richner M, Jager SB, Siupka P, Vaegter CB. Hydraulic extrusion of the spinal cord and isolation of dorsal root ganglia in rodents. J Vis Exp. 2017;55226. 10.3791/55226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5352284</ArticleId><ArticleId IdType="pubmed">28190031</ArticleId></ArticleIdList></Reference><Reference><Citation>Picelli S, et al. Smart-seq2 for sensitive full-length transcriptome profiling in single cells. Nat Methods. 2013;10:1096&#x2013;1098. doi: 10.1038/nmeth.2639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2639</ArticleId><ArticleId IdType="pubmed">24056875</ArticleId></ArticleIdList></Reference><Reference><Citation>Trapnell C, et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nature protocols. 2012;7:562&#x2013;578. doi: 10.1038/nprot.2012.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2012.016</ArticleId><ArticleId IdType="pmc">PMC3334321</ArticleId><ArticleId IdType="pubmed">22383036</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer A, Green J, Pollard J, Jr, Tugendreich S. Causal analysis approaches in ingenuity pathway analysis. Bioinformatics. 2014;30:523&#x2013;530. doi: 10.1093/bioinformatics/btt703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btt703</ArticleId><ArticleId IdType="pmc">PMC3928520</ArticleId><ArticleId IdType="pubmed">24336805</ArticleId></ArticleIdList></Reference><Reference><Citation>Caporaso JG, et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J. 2012;6:1621&#x2013;1624. doi: 10.1038/ismej.2012.8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ismej.2012.8</ArticleId><ArticleId IdType="pmc">PMC3400413</ArticleId><ArticleId IdType="pubmed">22402401</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox LM, et al. Gut microbiome in progressive multiple sclerosis. Ann Neurol. 2021;89:1195&#x2013;1211. doi: 10.1002/ana.26084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26084</ArticleId><ArticleId IdType="pmc">PMC8132291</ArticleId><ArticleId IdType="pubmed">33876477</ArticleId></ArticleIdList></Reference><Reference><Citation>Caporaso JG, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7:335&#x2013;336. doi: 10.1038/nmeth.f.303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.f.303</ArticleId><ArticleId IdType="pmc">PMC3156573</ArticleId><ArticleId IdType="pubmed">20383131</ArticleId></ArticleIdList></Reference><Reference><Citation>Yilmaz P, et al. The SILVA and &#x201c;All-species Living Tree Project (LTP)&#x201d; taxonomic frameworks. Nucleic Acids Res. 2014;42:D643&#x2013;D648. doi: 10.1093/nar/gkt1209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt1209</ArticleId><ArticleId IdType="pmc">PMC3965112</ArticleId><ArticleId IdType="pubmed">24293649</ArticleId></ArticleIdList></Reference><Reference><Citation>Segata N, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12:R60. doi: 10.1186/gb-2011-12-6-r60.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2011-12-6-r60</ArticleId><ArticleId IdType="pmc">PMC3218848</ArticleId><ArticleId IdType="pubmed">21702898</ArticleId></ArticleIdList></Reference><Reference><Citation>Bokulich NA, et al. q2-longitudinal: longitudinal and paired-sample analyses of microbiome data. mSystems. 2018;3. 10.1128/mSystems.00219-18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6247016</ArticleId><ArticleId IdType="pubmed">30505944</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox LM, et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell. 2014;158:705&#x2013;721. doi: 10.1016/j.cell.2014.05.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.05.052</ArticleId><ArticleId IdType="pmc">PMC4134513</ArticleId><ArticleId IdType="pubmed">25126780</ArticleId></ArticleIdList></Reference><Reference><Citation>Abriouel H, et al. The controversial nature of the Weissella genus: technological and functional aspects versus whole genome analysis-based pathogenic potential for their application in food and health. Front Microbiol. 2015;6. 10.3389/fmicb.2015.01197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4621295</ArticleId><ArticleId IdType="pubmed">26579103</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez Vis&#xf1;uk D, Savoy de Giori G, LeBlanc JG, de Moreno de LeBlanc A. Neuroprotective effects associated with immune modulation by selected lactic acid bacteria in a Parkinson&#x2019;s disease model. Nutrition. 2020;79-80:110995. doi: 10.1016/j.nut.2020.110995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2020.110995</ArticleId><ArticleId IdType="pubmed">32977125</ArticleId></ArticleIdList></Reference><Reference><Citation>Gres V, Kolter J, Erny D, Henneke P. The role of CNS macrophages in streptococcal meningoencephalitis. J Leukoc Biol. 2019;106:209&#x2013;218. doi: 10.1002/jlb.4mr1118-419r.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jlb.4mr1118-419r</ArticleId><ArticleId IdType="pubmed">30762892</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasek MJ, et al. A complement-microglial axis drives synapse loss during virus-induced memory impairment. Nature. 2016;534:538&#x2013;543. doi: 10.1038/nature18283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature18283</ArticleId><ArticleId IdType="pmc">PMC5452615</ArticleId><ArticleId IdType="pubmed">27337340</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T, et al. Microglial upregulation of progranulin as a marker of motor neuron degeneration. J Neuropathol Exp Neurol. 2010;69:1191&#x2013;1200. doi: 10.1097/NEN.0b013e3181fc9aea.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3181fc9aea</ArticleId><ArticleId IdType="pubmed">21107132</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdewyn S, De Muynck L, Van Den Bosch L, Robberecht W, Van Damme P. Progranulin does not affect motor neuron degeneration in mutant SOD1 mice and rats. Neurobiol Aging. 2013;34:2302&#x2013;2303. doi: 10.1016/j.neurobiolaging.2013.03.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.03.027</ArticleId><ArticleId IdType="pubmed">23608112</ArticleId></ArticleIdList></Reference><Reference><Citation>Martens LH, et al. Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury. J Clin Invest. 2012;122:3955&#x2013;3959. doi: 10.1172/JCI63113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI63113</ArticleId><ArticleId IdType="pmc">PMC3484443</ArticleId><ArticleId IdType="pubmed">23041626</ArticleId></ArticleIdList></Reference><Reference><Citation>Jinn S, et al. TMEM175 deficiency impairs lysosomal and mitochondrial function and increases &#x3b1;-synuclein aggregation. Proc Natl Acad Sci U S A. 2017;114:2389&#x2013;2394. doi: 10.1073/pnas.1616332114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1616332114</ArticleId><ArticleId IdType="pmc">PMC5338534</ArticleId><ArticleId IdType="pubmed">28193887</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu IM, et al. A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep. 2013;4:385&#x2013;401. doi: 10.1016/j.celrep.2013.06.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.06.018</ArticleId><ArticleId IdType="pmc">PMC4272581</ArticleId><ArticleId IdType="pubmed">23850290</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacher E, Levy M, Tatirovsky E, Elinav E. Microbiome-modulated metabolites at the interface of host immunity. J Immunol. 2017;198:572&#x2013;580. doi: 10.4049/jimmunol.1601247.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1601247</ArticleId><ArticleId IdType="pubmed">28069752</ArticleId></ArticleIdList></Reference><Reference><Citation>Olson CA, et al. The gut microbiota mediates the anti-seizure effects of the ketogenic diet. Cell. 2018;174:497. doi: 10.1016/j.cell.2018.06.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.06.051</ArticleId><ArticleId IdType="pmc">PMC6062008</ArticleId><ArticleId IdType="pubmed">30007420</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou Z, et al. Protective effects of Akkermansia muciniphila on cognitive deficits and amyloid pathology in a mouse model of Alzheimer&#x2019;s disease. Nutr Diabetes. 2020;10:12. doi: 10.1038/s41387-020-0115-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41387-020-0115-8</ArticleId><ArticleId IdType="pmc">PMC7176648</ArticleId><ArticleId IdType="pubmed">32321934</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YG, et al. Target intestinal microbiota to alleviate disease progression in amyotrophic lateral sclerosis. Clin Ther. 2017;39:322&#x2013;336. doi: 10.1016/j.clinthera.2016.12.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2016.12.014</ArticleId><ArticleId IdType="pmc">PMC5344195</ArticleId><ArticleId IdType="pubmed">28129947</ArticleId></ArticleIdList></Reference><Reference><Citation>Berard M, et al. Ralstonia pickettii-induced ataxia in immunodeficient mice. Comp Med. 2009;59:187&#x2013;191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2703153</ArticleId><ArticleId IdType="pubmed">19389312</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon PH, et al. Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. Lancet Neurol. 2007;6:1045&#x2013;1053. doi: 10.1016/S1474-4422(07)70270-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(07)70270-3</ArticleId><ArticleId IdType="pubmed">17980667</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>